A multicentre phase II study of docetaxel 75 mg m-2 as first-line chemotherapy for patients with advanced breast cancer: report of the Clinical Screening Group of the EORTC. European Organization for Research and Treatment of Cancer.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples